{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:03:58Z","timestamp":1791140638838,"version":"4.1.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.hoc.2005.08.002","type":"journal-article","created":{"date-parts":[[2005,11,7]],"date-time":"2005-11-07T10:44:29Z","timestamp":1131360269000},"page":"771-784","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":112,"title":["Sickle Cell Vaso-Occlusion"],"prefix":"10.1016","volume":"19","author":[{"given":"Elaine Y.","family":"Chiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul S.","family":"Frenette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hoc.2005.08.002_bib1","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1001\/archinte.1910.00050330050003","article-title":"Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia","volume":"6","author":"Herrick","year":"1910","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.hoc.2005.08.002_bib2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1001\/archinte.1927.00130020072006","article-title":"Sickle cell anemia","volume":"39","author":"Hahn","year":"1927","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.hoc.2005.08.002_bib3","first-page":"311","article-title":"Experimental studies of the sickling of red blood cells","volume":"22","author":"Hansen-Pruss","year":"1936","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.hoc.2005.08.002_bib4","first-page":"375","article-title":"Studies on a case of sickle cell anemia","volume":"23","author":"Scriver","year":"1930","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.hoc.2005.08.002_bib5","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1126\/science.110.2865.543","article-title":"Sickle cell anemia a molecular disease","volume":"110","author":"Pauling","year":"1949","journal-title":"Science"},{"key":"10.1016\/j.hoc.2005.08.002_bib6","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/180326a0","article-title":"Gene mutations in human haemoglobin: the chemical difference between normal and sickle cell haemoglobin","volume":"180","author":"Ingram","year":"1957","journal-title":"Nature"},{"key":"10.1016\/j.hoc.2005.08.002_bib7","first-page":"94","article-title":"Erythrocyte adherence to endothelium as a determinant of vasocclusive severity in sickle cell disease","volume":"93","author":"Hebbel","year":"1980","journal-title":"Trans Assoc Am Physicians"},{"key":"10.1016\/j.hoc.2005.08.002_bib8","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/blood.V54.4.872.872","article-title":"Adhesion of normal and sickle erythrocytes to endothelial monolayer cultures","volume":"54","author":"Hoover","year":"1979","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.08.002_bib9","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJM198005013021803","article-title":"Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity","volume":"302","author":"Hebbel","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2005.08.002_bib10","first-page":"153","article-title":"In vivo studies of sickle red blood cells","volume":"11","author":"Kaul","year":"2004","journal-title":"Microcirculation"},{"key":"10.1016\/j.hoc.2005.08.002_bib11","first-page":"102","article-title":"Erythrocyte adhesion in sickle cell disease","volume":"2","author":"Parise","year":"2003","journal-title":"Curr Hematol Rep"},{"key":"10.1016\/j.hoc.2005.08.002_bib12","first-page":"113","article-title":"Rheological studies of erythrocyte\u2013endothelial cell interactions in sickle cell disease","volume":"240","author":"Barabino","year":"1987","journal-title":"Prog Clin Biol Res"},{"key":"10.1016\/j.hoc.2005.08.002_bib13","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1073\/pnas.86.9.3356","article-title":"Microvascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions: pathophysiological implications","volume":"86","author":"Kaul","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.hoc.2005.08.002_bib14","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1172\/JCI112144","article-title":"Sickle erythrocyte adherence to vascular endothelium. Morphologic correlates and the requirement for divalent cations and collagen-binding plasma proteins","volume":"76","author":"Mohandas","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hoc.2005.08.002_bib15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/(SICI)1096-8652(199607)52:3<135::AID-AJH2>3.0.CO;2-U","article-title":"Effects of density and of dehydration of sickle cells on their adhesion to cultured endothelial cells","volume":"52","author":"Stone","year":"1996","journal-title":"Am J Hematol"},{"key":"10.1016\/j.hoc.2005.08.002_bib16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1152\/physrev.00052.2003","article-title":"Ion transport pathology in the mechanism of sickle cell dehydration","volume":"85","author":"Lew","year":"2005","journal-title":"Physiol Rev"},{"key":"10.1016\/j.hoc.2005.08.002_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/15513810109168815","article-title":"Prevention of red cell dehydration: a possible new treatment for sickle cell disease","volume":"20","author":"Mueller","year":"2001","journal-title":"Pediatr Pathol Mol Med"},{"key":"10.1016\/j.hoc.2005.08.002_bib18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.med.54.101601.152439","article-title":"Pathophysiological-based approaches to treatment of sickle cell disease","volume":"54","author":"Steinberg","year":"2003","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.hoc.2005.08.002_bib19","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1182\/blood.V97.1.312","article-title":"Lutheran blood group glycoprotein and its newly characterized mouse homologue specifically bind alpha5 chain\u2013containing human laminin with high affinity","volume":"97","author":"Parsons","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.08.002_bib20","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1172\/JCI1204","article-title":"Basal cell adhesion molecule\/lutheran protein. The receptor critical for sickle cell adhesion to laminin","volume":"101","author":"Udani","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hoc.2005.08.002_bib21","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1182\/blood-2004-07-2881","article-title":"Role of Rap1 in promoting sickle red blood cell adhesion to laminin via BCAM\/LU","volume":"105","author":"Murphy","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.08.002_bib22","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1182\/blood-2001-12-0289","article-title":"Novel epinephrine and cyclic AMP-mediated activation of BCAM\/Lu-dependent sickle (SS) RBC adhesion","volume":"101","author":"Hines","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.08.002_bib23","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1182\/blood-2004-01-0042","article-title":"Epinephrine acts through erythroid signaling pathways to activate sickle cell adhesion to endothelium via LW-alphavbeta3 interactions","volume":"104","author":"Zennadi","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.08.002_bib24","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/(SICI)1096-8652(199604)51:4<296::AID-AJH8>3.0.CO;2-R","article-title":"Disturbance of plasma and platelet thrombospondin levels in sickle cell disease","volume":"51","author":"Browne","year":"1996","journal-title":"Am J Hematol"},{"key":"10.1016\/j.hoc.2005.08.002_bib25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0925-4439(98)00085-4","article-title":"Mechanism of interaction of thrombospondin with human endothelium and inhibition of sickle erythrocyte adhesion to human endothelial cells by heparin","volume":"1453","author":"Gupta","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.hoc.2005.08.002_bib26","doi-asserted-by":"crossref","first-page":"42393","DOI":"10.1074\/jbc.M407631200","article-title":"Mechanism of CD47-induced alpha4beta1 integrin activation and adhesion in sickle reticulocytes","volume":"279","author":"Brittain","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.hoc.2005.08.002_bib27","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1182\/blood.V95.2.368","article-title":"Monoclonal antibodies to alphaVbeta3 (7E3 and LM609) inhibit sickle red blood cell\u2013endothelium interactions induced by platelet-activating factor","volume":"95","author":"Kaul","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.08.002_bib28","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1172\/JCI113151","article-title":"Unusually large von Willebrand factor multimers increase adhesion of sickle erythrocytes to human endothelial cells under controlled flow","volume":"80","author":"Wick","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hoc.2005.08.002_bib29","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/ajh.2830420308","article-title":"Unusually large von Willebrand factor multimers preferentially promote young sickle and nonsickle erythrocyte adhesion to endothelial cells","volume":"42","author":"Wick","year":"1993","journal-title":"Am J Hematol"},{"key":"10.1016\/j.hoc.2005.08.002_bib30","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1182\/blood.V95.4.1293.004k42_1293_1300","article-title":"Adherence of phosphatidylserine-exposing erythrocytes to endothelial matrix thrombospondin","volume":"95","author":"Manodori","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.08.002_bib31","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1182\/blood.V99.5.1564","article-title":"Role of erythrocyte phosphatidylserine in sickle red cell\u2013endothelial adhesion","volume":"99","author":"Setty","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.08.002_bib32","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1182\/blood-2004-02-0713","article-title":"The contribution of endothelial cell P-selectin to the microvascular flow of mouse sickle erythrocytes in vivo","volume":"104","author":"Embury","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.08.002_bib33","doi-asserted-by":"crossref","first-page":"H1608","DOI":"10.1152\/ajpheart.01056.2003","article-title":"Endothelial cell P-selectin mediates a proinflammatory and prothrombogenic phenotype in cerebral venules of sickle cell transgenic mice","volume":"286","author":"Wood","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.hoc.2005.08.002_bib34","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1182\/blood-2002-10-3313","article-title":"Transgenic sickle mice have vascular inflammation","volume":"101","author":"Belcher","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.08.002_bib35","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1056\/NEJM199711273372203","article-title":"Circulating activated endothelial cells in sickle cell anemia","volume":"337","author":"Solovey","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2005.08.002_bib36","doi-asserted-by":"crossref","first-page":"H293","DOI":"10.1152\/ajpheart.01150.2003","article-title":"Anti-inflammatory therapy ameliorates leukocyte adhesion and microvascular flow abnormalities in transgenic sickle mice","volume":"287","author":"Kaul","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.hoc.2005.08.002_bib37","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1182\/blood.V97.7.1937","article-title":"Modulation of endothelial cell activation in sickle cell disease: a pilot study","volume":"97","author":"Solovey","year":"2001","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.hoc.2005.08.002_bib38","doi-asserted-by":"crossref","first-page":"H2715","DOI":"10.1152\/ajpheart.00986.2004","article-title":"Critical role of endothelial cell activation in hypoxia-induced vaso-occlusion in transgenic sickle mice","volume":"288","author":"Belcher","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.hoc.2005.08.002_bib39","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00062752-200303000-00001","article-title":"An emerging role for nitric oxide in sickle cell disease vascular homeostasis and therapy","volume":"10","author":"Reiter","year":"2003","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.hoc.2005.08.002_bib40","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1182\/blood.V92.9.3445","article-title":"Enhanced adherence of sickle erythrocytes to thrombin-treated endothelial cells involves interendothelial cell gap formation","volume":"92","author":"Manodori","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.08.002_bib41","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1365-2141.1994.tb08318.x","article-title":"Circulating cytokines in sickle cell patients during steady state","volume":"87","author":"Croizat","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.hoc.2005.08.002_bib42","first-page":"611","article-title":"Elevated immunoreactive tumor necrosis factor and interleukin-1 in sickle cell disease","volume":"84","author":"Francis","year":"1992","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.hoc.2005.08.002_bib43","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1182\/blood-2002-11-3423","article-title":"Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor","volume":"102","author":"Selvaraj","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.08.002_bib44","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1182\/blood-2002-11-3422","article-title":"Placenta growth factor activates monocytes and correlates with sickle cell disease severity","volume":"102","author":"Perelman","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.08.002_bib45","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1182\/blood.V96.7.2451","article-title":"Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion","volume":"96","author":"Belcher","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.08.002_bib46","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0268-960X(03)00037-7","article-title":"The intriguing contribution of white blood cells to sickle cell disease\u2014a red cell disorder","volume":"18","author":"Okpala","year":"2004","journal-title":"Blood Rev"},{"key":"10.1016\/j.hoc.2005.08.002_bib47","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2005.08.002_bib48","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1542\/peds.103.3.640","article-title":"Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. The Cooperative Study of Sickle Cell Disease","volume":"103","author":"Kinney","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.hoc.2005.08.002_bib49","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1182\/blood.V89.5.1787","article-title":"Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative Study of Sickle Cell Disease","volume":"89","author":"Vichinsky","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.08.002_bib50","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","article-title":"Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia","volume":"332","author":"Charache","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2005.08.002_bib51","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0140-6736(05)60614-9","article-title":"Granulocytosis causing sickle-cell crisis","volume":"351","author":"Abboud","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.hoc.2005.08.002_bib52","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1182\/blood.V97.10.3313","article-title":"Fatal sickle cell crisis after granulocyte colony-stimulating factor administration","volume":"97","author":"Adler","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.08.002_bib53","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1182\/blood.V97.12.3998","article-title":"Granulocyte colony-stimulating factor\u2013induced sickle cell crisis and multiorgan dysfunction in a patient with compound heterozygous sickle cell\/beta+ thalassemia","volume":"97","author":"Grigg","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.08.002_bib54","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.1182\/blood.V87.10.4440.bloodjournal87104440","article-title":"Sickle erythrocytes adhere to polymorphonuclear neutrophils and activate the neutrophil respiratory burst","volume":"87","author":"Hofstra","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.08.002_bib55","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/ajh.20059","article-title":"Inflammatory potential of neutrophils detected in sickle cell disease","volume":"76","author":"Lum","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.hoc.2005.08.002_bib56","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1182\/blood.V91.1.266","article-title":"Blood polymorphonuclear leukocytes from the majority of sickle cell patients in the crisis phase of the disease show enhanced adhesion to vascular endothelium and increased expression of CD64","volume":"91","author":"Fadlon","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.08.002_bib57","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/jlb.66.3.411","article-title":"Neutrophil activation in sickle cell disease","volume":"66","author":"Lard","year":"1999","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.hoc.2005.08.002_bib58","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1172\/JCI9225","article-title":"Hypoxia\/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice","volume":"106","author":"Kaul","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hoc.2005.08.002_bib59","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1073\/pnas.052522799","article-title":"Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm","volume":"99","author":"Turhan","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.hoc.2005.08.002_bib60","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1749-6632.1989.tb24178.x","article-title":"Role of leukocyte\u2013endothelium adhesion in affecting recovery from ischemic episodes","volume":"565","author":"Lipowsky","year":"1989","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.hoc.2005.08.002_bib61","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00062752-200203000-00003","article-title":"Sickle cell vaso-occlusion: multistep and multicellular paradigm","volume":"9","author":"Frenette","year":"2002","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.hoc.2005.08.002_bib62","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/mic.11.2.167.177","article-title":"Sickle cell vasoocclusion: heterotypic, multicellular aggregations driven by leukocyte adhesion","volume":"11","author":"Frenette","year":"2004","journal-title":"Microcirculation"},{"key":"10.1016\/j.hoc.2005.08.002_bib63","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1084\/jem.183.5.2329","article-title":"Infectious susceptibility and severe deficiency of leukocyte rolling and recruitment in E-selectin and P-selectin double mutant mice","volume":"183","author":"Bullard","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.hoc.2005.08.002_bib64","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0092-8674(00)81032-6","article-title":"Susceptibility to infection and altered hematopoiesis in mice deficient in both P- and E-selectins","volume":"84","author":"Frenette","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.hoc.2005.08.002_bib65","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1182\/blood-2003-07-2209","article-title":"Intravenous immune globulin prevents venular vaso-occlusion in sickle cell mice by inhibiting leukocyte adhesion and the interactions between sickle erythrocytes and adherent leukocytes","volume":"103","author":"Turhan","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.08.002_bib66","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00277-004-0895-2","article-title":"Thromboembolic events as an emerging adverse effect during high-dose intravenous immunoglobulin therapy in elderly patients: a case report and discussion of the relevant literature","volume":"83","author":"Hefer","year":"2004","journal-title":"Ann Hematol"},{"key":"10.1016\/j.hoc.2005.08.002_bib67","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000081465","article-title":"Thromboembolic complications of intravenous immunoglobulin treatment","volume":"52","author":"Vucic","year":"2004","journal-title":"Eur Neurol"},{"key":"10.1016\/j.hoc.2005.08.002_bib68","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1161\/01.STR.10.4.464","article-title":"Circulating platelet aggregates in sickle cell disease patients with and without vaso-occlusion","volume":"10","author":"Mehta","year":"1979","journal-title":"Stroke"},{"key":"10.1016\/j.hoc.2005.08.002_bib69","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1067\/mlc.2001.115450","article-title":"Thrombogenesis in sickle cell disease","volume":"137","author":"Tomer","year":"2001","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.hoc.2005.08.002_bib70","first-page":"44","article-title":"Platelet function and survival in sickle cell disease","volume":"82","author":"Haut","year":"1973","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.hoc.2005.08.002_bib71","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/15513810109168816","article-title":"Hemostatic alterations in sickle cell disease: relationships to disease pathophysiology","volume":"20","author":"Stuart","year":"2001","journal-title":"Pediatr Pathol Mol Med"},{"key":"10.1016\/j.hoc.2005.08.002_bib72","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1182\/blood-2003-03-0693","article-title":"Sickle blood contains tissue factor\u2013positive microparticles derived from endothelial cells and monocytes","volume":"102","author":"Shet","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.08.002_bib73","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1182\/blood.V98.3.860","article-title":"Characterization of the phosphatidylserine-exposing subpopulation of sickle cells","volume":"98","author":"de Jong","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.08.002_bib74","first-page":"741","article-title":"Measurement of membrane phospholipid asymmetry in normal and sickle-cell erythrocytes by means of annexin V binding","volume":"123","author":"Tait","year":"1994","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.hoc.2005.08.002_bib75","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1055\/s-0038-1650055","article-title":"Aspirin-dipyridamole prophylaxis of sickle cell disease pain crises","volume":"43","author":"Chaplin","year":"1980","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hoc.2005.08.002_bib76","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000207105","article-title":"Therapeutic effect of aspirin in sickle cell anaemia","volume":"66","author":"Osamo","year":"1981","journal-title":"Acta Haematol"},{"key":"10.1016\/j.hoc.2005.08.002_bib77","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0022-3476(83)80258-3","article-title":"Trial of low doses of aspirin as prophylaxis in sickle cell disease","volume":"102","author":"Greenberg","year":"1983","journal-title":"J Pediatr"},{"key":"10.1016\/j.hoc.2005.08.002_bib78","first-page":"199","article-title":"Clinical and biological double-blind-study of ticlopidine in preventive treatment of sickle-cell disease crises","volume":"15","author":"Cabannes","year":"1984","journal-title":"Agents Actions Suppl"},{"key":"10.1016\/j.hoc.2005.08.002_bib79","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1055\/s-0038-1661088","article-title":"A double-blind trial of ticlopidine in sickle cell disease","volume":"51","author":"Semple","year":"1984","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hoc.2005.08.002_bib80","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1182\/blood.V93.4.1422","article-title":"Anionic polysaccharides inhibit adhesion of sickle erythrocytes to the vascular endothelium and result in improved hemodynamic behavior","volume":"93","author":"Barabino","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.08.002_bib81","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1182\/blood-2002-02-0626","article-title":"Heparin inhibits the flow adhesion of sickle red blood cells to P-selectin","volume":"100","author":"Matsui","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.08.002_bib82","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.0902-4441.2003.00209.x","article-title":"Effect of low-dose warfarin on D-dimer levels during sickle cell vaso-occlusive crisis: a brief report","volume":"72","author":"Ahmed","year":"2004","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.hoc.2005.08.002_bib83","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1365-2141.1995.tb05607.x","article-title":"Low-intensity oral anticoagulation in sickle-cell disease reverses the prethrombotic state: promises for treatment?","volume":"90","author":"Wolters","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.hoc.2005.08.002_bib84","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ajh.1175","article-title":"Low adjusted-dose acenocoumarol therapy in sickle cell disease: a pilot study","volume":"68","author":"Schnog","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1016\/j.hoc.2005.08.002_bib85","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ajh.10178","article-title":"No effect of acenocoumarol therapy on levels of endothelial activation markers in sickle cell disease","volume":"71","author":"Schnog","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1016\/j.hoc.2005.08.002_bib86","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/ajh.2830340110","article-title":"Enhancement of sickle erythrocyte adherence to endothelium by autologous platelets","volume":"34","author":"Antonucci","year":"1990","journal-title":"Am J Hematol"},{"key":"10.1016\/j.hoc.2005.08.002_bib87","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1365-2257.2002.t01-1-00433.x","article-title":"Activated monocytes and platelet-monocyte aggregates in patients with sickle cell disease","volume":"24","author":"Wun","year":"2002","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.hoc.2005.08.002_bib88","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1365-2141.2000.02353.x","article-title":"Platelet and leucocyte activation in childhood sickle cell disease: association with nocturnal hypoxaemia","volume":"111","author":"Inwald","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.hoc.2005.08.002_bib89","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/S0140-6736(03)14689-2","article-title":"Hypoxaemia in sickle cell disease: biomarker modulation and relevance to pathophysiology","volume":"362","author":"Setty","year":"2003","journal-title":"Lancet"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858805000924?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858805000924?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:38:30Z","timestamp":1760182710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858805000924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":89,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0889858805000924"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2005.08.002","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sickle Cell Vaso-Occlusion","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2005.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}